Affimed KOL Event Dec 7

New York, December 7, 2018

Affimed cordially invites you to join management and key opinion leaders for a breakfast in New York City. 

General Agenda

Date:
Friday, December 7

Time:
8:00 am Registration and Breakfast
8:30 am - 11 am Presentations and Q&A

Location:
Convene -  810 7th Avenue, Between 52nd & 53rd St, NYC

KOL Speakers:
Dr. Steven M. Horwitz - Memorial Sloan Kettering Cancer Center
Dr. Yago Nieto - The University of Texas MD Anderson Cancer Center
Dr. Ahmed Sawas - Columbia University College of Physicians and Surgeons and the New York-Presbyterian Hospital

RSVP for Event / Log Back in

Additional menu options can be found in the menu bar on the left or at the top.

Affimed N.V. [AFMD] US$227 MM MCap
NK cell en­gager AFM13 (CD30/CD16A) that is poised to en­ter a Phase 2 reg­is­tra­tion study in CD30-pos­i­tive pe­ripher­al T cell lym­pho­ma and an in­vesti­ga­tor-spon­sored study by MDACC of AFM13 com­bined with al­lo­gene­ic NK cells in re­lapsed/re­frac­to­ry CD30-pos­i­tive lym­pho­ma. Af­fimed al­so plans to file an IND in the third quar­ter of 2019 for AFM24, the com­pany’s in­nate cell en­gager that tar­gets EGFR-ex­press­ing solid tu­mors. [more in­for­ma­tion]

Event Contact

Rebecca John
Solebury Trout

Location of the Event and Other Places